Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces that President and CEO Rick Eiswirth will present at the H.C. Wainwright Global Life Sciences Conference to be held on March 9-10, 2021.

The presentation will be available on-demand beginning March 9 at 7:00 am ET and be available for 90 days. Investors can view the presentation by registering for the conference here. Mr. Eiswirth will be available for virtual one-on-one meetings with investors on March 9-10, and meeting requests can be made on the conference website once an investor is registered.

About Alimera Sciences, Inc.

Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations. For more information, please visit www.alimerasciences.com.

For press inquiries:Jules Abrahamfor Alimera Sciences917-885-7378julesa@coreir.com

For investor inquiries:Scott Gordonfor Alimera Sciencesscottg@coreir.com

        

# # #